Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥5.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.0bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥400m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥507m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥418m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥639m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥519m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥417m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥561m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥297m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥469m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥365m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥297m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥365m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥9.4bnat 2023-12-31Cons.Assets
Total assets¥9.3bnat 2023-03-31Cons.Assets
Total assets¥9.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥3.3bnat 2023-12-31Cons.Liabilities
Total liabilities¥3.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥6.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥5.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥5.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥2.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥106.792023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.592023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥169.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥131.722022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.342022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio64.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥861,000
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥103m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥535m
—segment totalrevenue2023-04-01 → 2023-12-31¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥3.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥861,000
—segment totalsegment profit2023-04-01 → 2023-12-31¥638m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥861,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥638m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥73m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥644m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
—segment totalsegment profit2022-04-01 → 2022-12-31¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥717m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)監査法人グラヴィタス
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)藤 本 良 治
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)飯 田 一 紀
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration3965370000JPY
Net sales (5-year summary)CurrentYTDDuration3929420000JPY
Net sales (5-year summary)Prior1YearDuration5315220000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration519428000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration417531000JPY
Ordinary income loss (5-year summary)Prior1YearDuration639434000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration365204000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration297176000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration469191000JPY
Comprehensive income (5-year summary)Prior1YTDDuration365234000JPY
Comprehensive income (5-year summary)CurrentYTDDuration308179000JPY
Comprehensive income (5-year summary)Prior1YearDuration487402000JPY
Net assets (5-year summary)Prior1QuarterInstant5711262000JPY
Net assets (5-year summary)CurrentQuarterInstant6085196000JPY
Net assets (5-year summary)Prior1YearInstant5833431000JPY
Total assets (5-year summary)Prior1QuarterInstant9464963000JPY
Total assets (5-year summary)CurrentQuarterInstant9413919000JPY
Total assets (5-year summary)Prior1YearInstant9328014000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration131.72
Basic earnings loss per share (5-year summary)CurrentYTDDuration106.79
Basic earnings loss per share (5-year summary)Prior1YearDuration169.17
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.603
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.646
Equity to asset ratio (5-year summary)Prior1YearInstant0.625
Basic earnings loss per share (5-year summary)Prior1QuarterDuration34.34
Basic earnings loss per share (5-year summary)CurrentQuarterDuration28.59
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember3092623
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember3092623
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant3092623
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant3092623
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember12600
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember3061700
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember30617
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember18323
Number of shares issued shares voting rightsCurrentQuarterInstant3092623
Number of voting rights issued shares voting rightsCurrentQuarterInstant30617
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member12600
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass